"Children's Health is home to the largest childhood cancer & blood disorders center in North Texas, we treat one in five children in Texas diagnosed with cancer. From bleeding disorders - oncology services, we are one of the nation’s premier programs for children with malignant disorders. Learn more."

During the past decade, Children's Medical Center, Dallas Center for Cancer and Blood Disorders conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Children's Medical Center, Dallas Center for Cancer and Blood Disorders" #1 collaborator was "Cook Children's Medical Center" with 1 trials as a collaborator, "M.D. Anderson Cancer Center" with 1 trials as a collaborator, "The University of Texas Health Science Center at San Antonio" with 1 trials as a collaborator, "University of Oklahoma" with 1 trials as a collaborator and "University of Texas, Southwestern Medical Center at Dallas" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Children's Medical Center, Dallas Center for Cancer and Blood Disorders" are "Anaplastic Astrocytoma" (1 trials), "Brainstem Glioma" (1 trials), "Diffuse Intrinsic Pontine Glioma" (1 trials), "Glial Cell Tumors" (1 trials) and "Glioblastoma Multiforme" (1 trials). Many other conditions were trialed in "Children's Medical Center, Dallas Center for Cancer and Blood Disorders" in a lesser frequency.

Most popular intervention types in "Children's Medical Center, Dallas Center for Cancer and Blood Disorders" are "Drug" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (1 trials), "Radiation therapy" (1 trials), "Valproic acid" (1 trials), "erlotinib" (1 trials) and "etoposide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Children's Medical Center, Dallas Center for Cancer and Blood Disorders" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Children's Medical Center, Dallas Center for Cancer and Blood Disorders". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Children's Medical Center, Dallas Center for Cancer and Blood Disorders, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Children's Medical Center, Dallas Center for Cancer and Blood Disorders, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".